Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muci...
Guardado en:
Autores principales: | Brendan A. Daisley, Ryan M. Chanyi, Kamilah Abdur-Rashid, Kait F. Al, Shaeley Gibbons, John A. Chmiel, Hannah Wilcox, Gregor Reid, Amanda Anderson, Malcolm Dewar, Shiva M. Nair, Joseph Chin, Jeremy P. Burton |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d057b42a310240ed8e3bbeaf06f35107 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
por: Brendan A. Daisley, et al.
Publicado: (2020) -
Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila
por: Bradford Becken, et al.
Publicado: (2021) -
Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
por: Renee L. Greer, et al.
Publicado: (2016) -
Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer
por: Ayşe Demirci, et al.
Publicado: (2021) -
Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice
por: Fatemeh Ashrafian, et al.
Publicado: (2021)